about
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionNeuroprotective Activity of Hypericum perforatum and Its Major ComponentsHypericin in the Light and in the Dark: Two Sides of the Same CoinAnthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological ActivitiesNanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A ReviewAntimicrobial photodynamic therapy to kill Gram-negative bacteriaPhotodynamic therapy and cancer: a brief sightseeing tour.Hyperforin accumulates in the translucent glands of Hypericum perforatum.Hypericins as potential leads for new therapeuticsAnalysis of Breeding Systems, Ploidy, and the Role of Hexaploids in Three Hypericum perforatum L. Populations.New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.Probing the molecular mechanism of hypericin-induced parasite death provides insight into the role of spermidine beyond redox metabolism in Leishmania donovani.Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds.Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds.Spatial chemo-profiling of hypericin and related phytochemicals in Hypericum species using MALDI-HRMS imaging.Fluorinated porphyrinoids as efficient platforms for new photonic materials, sensors, and therapeutics.Occurrence and Distribution of Phytochemicals in the Leaves of 17 In vitro Cultured Hypericum spp. Adapted to Outdoor Conditions.Subdiffraction localization of a nanostructured photosensitizer in bacterial cells.Is it safe to use antidepressants after a stroke?Alternative Oxidase Gene Family in Hypericum perforatum L.: Characterization and Expression at the Post-germinative Phase.A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice.Anticancer compounds derived from fungal endophytes: their importance and future challenges.ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.Hypericins: biotechnological production from cell and organ cultures.Crystallization and preliminary crystallographic studies of Hyp-1, a St John's wort protein implicated in the biosynthesis of hypericinPhotosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro.Antiviral activity of Rheum palmatum methanol extract and chrysophanol against Japanese encephalitis virus.St. John's Wort Potentiates anti-Nociceptive Effects of Morphine in Mice Models of Neuropathic Pain.St. John's wort relieves pain in an animal model of migraine.High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL.Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin.The association between self-reported cataracts and St. John's Wort.Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.Octaketide-producing type III polyketide synthase from Hypericum perforatum is expressed in dark glands accumulating hypericins.Interspecific variation in localization of hypericins and phloroglucinols in the genus Hypericum as revealed by desorption electrospray ionization mass spectrometry imaging.Purification of Glutathione S-Transferase pi from Erythrocytes and Evaluation of the Inhibitory Effect of Hypericin.Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro.Pilot-scale culture of Hypericum perforatum L. adventitious roots in airlift bioreactors for the production of bioactive compounds.Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
P2860
Q21089597-DE74D07D-AE1E-45FB-88E4-E83F2273E8E9Q26741405-5C559D06-C390-404B-9AC6-56F572C220DCQ26747362-15DA7397-F788-4964-AED2-5C4D9A04B0F7Q26749631-0D0502EC-827A-4B95-B390-E7BE76FB529DQ26765475-EA1DC034-17E4-493B-B369-D8223A117D42Q26866247-FE9BB4B9-92EC-4427-97A8-805296AFC8D5Q33276646-7ED88796-9E8A-4AAE-B5C5-E7B1FCF7A63DQ33283160-EF24E8F2-61E5-48DE-A875-71C7E82295DBQ33553257-043E2380-9E11-4D39-8576-5A97CEA9AA3EQ33822070-8E0D52BB-EE5A-40AB-9019-113D0C38ED41Q34085422-A0E8BB65-31AC-4D6F-899C-E0127CA8589CQ34517469-0C8D603F-AD27-4909-A0F6-4605CA9C7752Q34922108-1C5EF8BF-8AF3-414C-B624-8B5382F8C8ACQ35012539-7BD6CB9C-A2B3-44FD-BE61-BDFCE902B957Q35103698-B11AEA16-AF82-4478-B466-8624E6B994E0Q35614570-0509B2B5-9B06-4BED-8CB6-B24013DB2487Q35826474-E2F62470-6A46-415F-AC86-4480B27CF5DCQ36189431-78338BEE-750C-4614-A86B-ACDB2FB13B38Q36192616-2FCD1186-A1B8-4576-A27E-3E79EC109BE1Q36235515-EB5CF54A-A315-4E7D-833F-27B842DD3625Q37166013-C72BD2C0-4778-4E25-B506-189ABEED9BB6Q37727160-68AA9B25-DA8F-49C7-9C83-31EE3B393B6BQ37860171-DAAE9C04-DD3F-4BA6-B30A-6FEB01966346Q38184935-C22A5BE6-8132-49A3-8289-77678B014201Q38258706-C2082FF9-3CED-4DE0-8B0E-09C30B100797Q38294638-E9FB2C18-A1AB-4079-BA5F-8D90C9D39415Q39009629-894B0323-2B55-4C25-8588-665CE9CAAEA6Q39036950-72426FBE-1135-45F2-BEB7-B17D1C0854FFQ39166639-3BBF5A65-FA5F-4D61-9DF4-03530A3BE9CDQ39238341-A6C21D0C-2E3E-455C-BA47-081136232E81Q40028585-DB590521-D592-4AE3-8682-F56E8FAC8E2BQ41867023-BD858316-00D6-41A0-93C9-E0BF7A883836Q43247029-920674C8-670B-4CD8-A5F4-6F3E9F170FBDQ44452260-0D5AFBE5-D52D-47F3-89EB-0D0607AA016FQ45075783-8B425CAC-B7EF-49D2-B6AF-91DC602D4AA0Q46603480-7C97FD0E-DE89-4AD3-9931-3C57FA6F6569Q46632548-71749ED7-4523-4359-AC9F-C96E8D58CB63Q46824451-226645FC-D236-4A10-BFF4-0C4C97618ED5Q46856223-AE395440-CF71-4C25-B74E-8BD6092BFD3CQ49299129-A57B69CF-DA97-4AAB-BB44-B10A37FDE7EA
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hypericin--the facts about a controversial agent.
@ast
Hypericin--the facts about a controversial agent.
@en
Hypericin--the facts about a controversial agent.
@nl
type
label
Hypericin--the facts about a controversial agent.
@ast
Hypericin--the facts about a controversial agent.
@en
Hypericin--the facts about a controversial agent.
@nl
prefLabel
Hypericin--the facts about a controversial agent.
@ast
Hypericin--the facts about a controversial agent.
@en
Hypericin--the facts about a controversial agent.
@nl
P2093
P356
P1476
Hypericin--the facts about a controversial agent.
@en
P2093
P304
P356
10.2174/1381612053382287
P577
2005-01-01T00:00:00Z